Cox-2 expression in the oxyphilic cells of the normal, hyperplastic, and adenomatous parathyroid gland
- PMID: 15067174
- DOI: 10.1385/ep:15:1:29
Cox-2 expression in the oxyphilic cells of the normal, hyperplastic, and adenomatous parathyroid gland
Abstract
We investigated cyclooxygenase expression in parathyroid glands from patients with various pathological conditions in order to coordinate levels of immunoreactivity with histology, with preoperative serum levels of calcium, phosphate, and intact parathyroid hormone, and with clinical diagnoses. Surgical specimens were obtained from 38 patients diagnosed with adenoma and primary, secondary, and tertiary hyperplasias. Incidentally removed parathyroids served as controls. After routine histological processing, approximations of total area and area of oncocytic nodules were calculated for each section of gland. Immunohistochemical reactivities for Cox-1, Cox-2, and values for integrated Cox-2 reactivity were quantified and compared with the clinical diagnoses and preoperative serum biochemistry. For the pooled cases, serum phosphate and PTH were directly related to each other, to total glandular area, and to integrated oncocytic area. Serum calcium was inversely related to serum phosphate and PTH levels as well as to total gland size. Within the adenoma group, the pure chief cell adenoma patients were younger and their tumors showed greater proliferative activity than those in the oncocytic adenoma group. For secondary and tertiary hyperplasias, the number of oncocytic nodules was significantly higher than in the adenomas and primary hyperplasias. In our study, the oncocytic cells are the only demonstrable site of Cox activity. It is suggested that the oncocytic cells play a role in prostaglandin metabolism within the parathyroids and may have a role in the regulation of PTH secretion.
Similar articles
-
Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism.Pathol Oncol Res. 2004;10(2):98-103. doi: 10.1007/BF02893463. Epub 2004 Jun 9. Pathol Oncol Res. 2004. PMID: 15188026
-
Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism.World J Surg. 1996 Oct;20(8):1010-4; discussion 1014-5. doi: 10.1007/s002689900154. World J Surg. 1996. PMID: 8798358
-
Adrenomedullin immunoreactivity tissue distribution in parathyroids of the patients with primary hyperparathyroidism.Horm Metab Res. 2004 Jul;36(7):480-4. doi: 10.1055/s-2004-825731. Horm Metab Res. 2004. PMID: 15305232
-
Hyperplasia in glands with hormone excess.Endocr Relat Cancer. 2016 Jan;23(1):R1-14. doi: 10.1530/ERC-15-0171. Epub 2015 Sep 25. Endocr Relat Cancer. 2016. PMID: 26407873 Free PMC article. Review.
-
Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue.Pathol Oncol Res. 2005;11(1):45-9. doi: 10.1007/BF03032405. Epub 2005 Mar 31. Pathol Oncol Res. 2005. PMID: 15800682 Review.
Cited by
-
Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice.Bone. 2010 Aug;47(2):341-52. doi: 10.1016/j.bone.2010.05.006. Epub 2010 May 13. Bone. 2010. PMID: 20471507 Free PMC article.
-
Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease.Int J Mol Sci. 2020 Jun 18;21(12):4332. doi: 10.3390/ijms21124332. Int J Mol Sci. 2020. PMID: 32570711 Free PMC article. Review.
-
Molecular Mechanisms of Parathyroid Disorders in Chronic Kidney Disease.Metabolites. 2022 Jan 25;12(2):111. doi: 10.3390/metabo12020111. Metabolites. 2022. PMID: 35208186 Free PMC article. Review.
-
Cyclooxygenase 2 promotes parathyroid hyperplasia in ESRD.J Am Soc Nephrol. 2011 Apr;22(4):664-72. doi: 10.1681/ASN.2010060594. Epub 2011 Feb 18. J Am Soc Nephrol. 2011. PMID: 21335517 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials